Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger



Status:Enrolling by invitation
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:7/13/2018
Start Date:May 10, 2018
End Date:December 2019

Use our guide to learn which trials are right for you!

Injection With Amniotic Fluid Versus Corticosteroid in Patients With Stenosing Tenosynovitis: a Randomized, Blinded Trial

The proposed study aims to investigate whether amniotic fluid injections are a better
alternative to corticosteroid injections as a conservative treatment for stenosing
tenosynovitis. Based on results from our most recent pilot study exploring patient outcomes
after receiving an amnion injection, we were able to observe symptom resolution in more than
half of the study population. Adverse events were extremely rare and not related to study
participation. Given the numerous occurrences of successful symptom resolution, the next step
is to compare patient outcomes to those of patients who receive the standard steroid
injection. This study will compare outcome measurements of patients who receive amnion
injections to those who receive steroid injections.


Inclusion Criteria:

- Patient is at least 18 years of age

- Patient is diagnosed with stenosing tenosynovitis

Exclusion Criteria:

- Patient is less than 18 years of age

- Pregnancy

- Enrolling clinician does not believe that the patient is mentally capable of
understanding the research nature of the procedure due to mental handicap/disability
or illiteracy.
We found this trial at
1
site
Athens, Georgia 30606
?
mi
from
Athens, GA
Click here to add this to my saved trials